Nafamostat, also known as FUT-175, is a serine protease inhibitor and an anticoagulant. Nafamostat promotes endothelium-dependent vasorelaxation via the Akt-eNOS dependent pathway. Nafamostat Attenuates Ischemia-Reperfusion-Induced Renal Injury. Nafamostat Attenuates Ischemia-Reperfusion-Induced Renal Injury. Nafamostat protects against acute cerebral ischemia via blood-brain barrier protection. Nafamostat Inhibits TNF-α-Induced Vascular Endothelial Cell Dysfunction by Inhibiting Reactive Oxygen Species Production.
Properties:
Density: 1.39g/cm3
Boiling Point: 637.2ºC at 760 mmHg
Flash Point: 339.1ºC
Refractive: Index 1.694
Serine Protease Inhibitors Related Products:
Aprotinin; Alvelestat; Leupeptin hemisulfate; Nafamostat mesylate; PMSF; AEBSF hydrochloride